Results 111 to 120 of about 2,246,140 (208)

The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia

open access: yes, 2000
ObjectivesTo describe the impact of maternal serum screening on the birth prevalence of Down's syndrome and on the use of amniocentesis and chorionic villus sampling in South Australia.DesignA descriptive population-based study.SettingSouth Australia ...
Ryall, R.   +11 more
core   +1 more source

Semi‐Automated Platform for Early Prenatal Coelocentesis Testing Using Electrospun Nanofiber Technology

open access: yesMacromolecular Materials and Engineering
Prenatal diagnostics play a critical role in identifying fetal disease conditions, particularly rare genetic disorders that significantly contribute to infant morbidity and mortality.
Emanuela Muscolino   +3 more
doaj   +1 more source

Foetal loss after chorionic villus sampling and amniocentesis in twin pregnancies: A multicentre retrospective cohort study. [PDF]

open access: yesPrenat Diagn, 2022
Navaratnam K   +14 more
europepmc   +1 more source

Disparities in antenatal care utilization and stillbirth risk among women of other origin than high‐income Western countries in Stockholm 2000–2020: A retrospective cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2030-2040, October 2026.
Women of other origin than high‐income Western Countries, particularly women originating from sub‐Saharan Africa, had fewer antenatal care visits and a higher proportion of inpatient care occasions compared to women from high‐income Western Countries. Abstract Introduction Foreign‐born women face a higher risk of adverse pregnancy outcomes, including ...
Minna Lundén   +3 more
wiley   +1 more source

Chorionic Villus Sampling

open access: yesJournal of Fetal Medicine, 2017
AbstractChorionic villus sampling (CVS) is a form of prenatal diagnosis to determine chromosomal or genetic disorders in the fetus. It entails sampling of the chorionic villus (placental tissue) and testing it for chromosomal abnormalities. It usually takes place at 10–12 weeks’ gestation, earlier than amniocentesis or percutaneous umbilical cord blood
openaire   +1 more source

Effects of GLP‐1 agonists on the gut microbiota in type 2 diabetes mellitus: a systematic review

open access: yesThe FEBS Journal, Volume 293, Issue 20, Page 5971-5995, October 2026.
This systematic review evaluated 17 studies (12 preclinical and five clinical) on GLP‐1 receptor agonists in type 2 diabetes, demonstrating effects on the gut microbiota and metabolic improvement. The studies showed an increase in Bacteroidetes, Lactobacillus, and Akkermansia, and a reduction in Firmicutes.
Ranicleide Santos Dantas   +11 more
wiley   +1 more source

Can It Happen Again? Using Co‐Produced Theatre to Explore the Challenges Faced by Couples Considering Pregnancy After a De Novo Genetic Diagnosis in a Child

open access: yesHealth Expectations, Volume 29, Issue 5, October 2026.
ABSTRACT Introduction When a couple has a child with a genetic condition, it raises questions when considering future pregnancies. It has typically been considered an easier genetic test result to receive when the condition is de novo (new) in origin, because neither parent is understood to have passed on the genetic change, except in rare cases ...
Alison Kay   +9 more
wiley   +1 more source

Darier disease—A review highlighting new insights from the Darier Disease International Task Force

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1626-1647, October 2026.
This review provides a global, clinically focused overview of DD, detailing cutaneous and extracutaneous manifestations, disease classification and severity scoring. It emphasizes early recognition, multidisciplinary management and practical guidance for dermatologists to apply evidence‐based care in diverse skin phototypes. Abstract Darier disease (DD)
Sofia Labbouz   +49 more
wiley   +1 more source

Home - About - Disclaimer - Privacy